Nonaromatic Sulfonamide Group as an Ideal Anchor for Potent Human Carbonic Anhydrase Inhibitors: Role of Hydrogen-Bonding Networks in Ligand Binding and Drug Design-Reference-Cited by-同舟云学术

Nonaromatic Sulfonamide Group as an Ideal Anchor for Potent Human Carbonic Anhydrase Inhibitors: Role of Hydrogen-Bonding Networks in Ligand Binding and Drug Design

Published:2002-07-12 Issue:17 Volume:45 Page:3583-3587
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Abbate Francesco¹,Supuran Claudiu T.¹,Scozzafava Andrea¹,Orioli Pierluigi¹,Stubbs Milton T.¹,Klebe Gerhard¹

Affiliation:

1. Laboratorio di Chimica Inorganica e Bioinorganica, Università degli Studi di Firenze, Via Gino Capponi 7, I-50121, Florence, Italy, and Department of Pharmaceutical Chemistry, Philipps University of Marburg, Marbacher Weg 6, 35032 Marburg, Germany

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm011131t

Reference28 articles.

1. The Carbonic Anhydrases

2. Carbonic anhydrase inhibitors and their therapeutic potential

3. Catalysis By Metal-Activated Hydroxide in Zinc and Manganese Metalloenzymes

Cited by 150 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. One-pot synthesis of N-acylated ureas using phenyliodine (III) diacetate (PIDA) as N-acylation agent;Tetrahedron Letters;2023-09

2. A simple yet multifaceted 90 years old, evergreen enzyme: Carbonic anhydrase, its inhibition and activation;Bioorganic & Medicinal Chemistry Letters;2023-09

3. Structural and theoretical study of π-stacking interactions in new complexes based on CuCl2 and 3-sulfonamide-substituted imidazo[2,1-b]thiazoles;Journal of Molecular Modeling;2023-04-12

4. Inhibition studies with simple and complex (in)organic anions of the γ-carbonic anhydrase from Mammaliicoccus (Staphylococcus) sciuri, MscCAγ;Journal of Enzyme Inhibition and Medicinal Chemistry;2023-01-31

5. Sulfonamide Moiety as “Molecular Chimera” in the Design of New Drugs;Current Medicinal Chemistry;2023-01